使用FDA不良事件报告系统数据库对瑞马佐拉姆的不良事件信号分析
Hongtao Liu1, Zhaoyu Li2, Su Yan2
1Guangxi Health Science College, Nanning, China.
Acta anaesthesiologica Scandinavica
|February 13, 2025
概括
雷米马佐拉姆是一种超短效麻醉剂,在老年患者中显示不良事件增加,特别是过敏反应和心脏/呼吸系统问题. 警监测和谨慎使用对于患者安全至关重要.
科学领域:
- 麻醉学 麻醉学
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
背景情况:
- 雷米马佐拉姆是一种新型的超短效二甲,在麻醉中获得了吸引力.
- 越来越多的使用需要全面评估安全概况.
- 关于副作用的有限数据要求进行更广泛的调查.
研究的目的:
- 系统地调查与remimazolam相关的不良药物事件 (ADEs).
- 使用现实数据识别潜在的安全信号.
- 为临床实践和监管行动提供信息.
主要方法:
- 使用FDA不良事件报告系统 (FAERS) 数据库的观察性研究.
- 从2020年第一季度到2023年第四季度分析的数据.
- 专注于识别和描述与remimazolam相关的ADEs.
主要成果:
- 确诊了67例病例和161例副发病.
- 在45岁以上的患者中观察到较高的ADE发病率,特别是65岁以上的患者.
- 关键的安全信号包括过敏反应,呼吸/心脏骤停和血管通道封闭.
结论:
- 临床医生必须警雷米马佐拉姆可能引起过敏反应,特别是在老年患者中.
- 由于数据有限,非标签使用应谨慎处理.
- 持续的市场后监测对于检测和管理ADEs至关重要.
相关概念视频
01:15REM Sleep Behavior Disorder
130
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
130
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143